But this cash has special meaning to her: The stack of one dollar bills was the last bit she saved up from a tip jar. Ella explains how she used to save up in increments of 100, and how she wanted to ...

Natco Pharma Ltd share price was down by -0.65% from the previous closing price of ₹1,328.00. Who are peers of Natco Pharma Ltd? The peers of Natco Pharma Ltd are Sun Pharmaceuticals Industries ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

Natco Pharma announced final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc. NATCO's marketing partner for ...

Drug maker Natco Pharma on Monday, February 10, announced securing the final approval from the United States Food and Drug Administration (USFDA) for its Bosentan tablets, which are used in treating ...

Natco Pharma said that it has received final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), which is a generic version of Tracleer by Actelion Pharmaceuticals US Inc. The ...

Return on investment - most recent fiscal year 25.46 ...

Cash Taxes Paid 286.30 177.50 48.20 130.00 ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 22,961.89 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

The Quarterly Results page of Natco Pharma Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

NATCO announces the final approval of its ANDA for Bosentan tablets ...

Featured here, the Cash Flow Statement for Natco Pharma Ltd., showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of ...